NEULASTA - 54868-5229-0 - (pegfilgrastim)

Alphabetical Index


Drug Information of NEULASTA

Product NDC: 54868-5229
Proprietary Name: NEULASTA
Non Proprietary Name: pegfilgrastim
Active Ingredient(s): 6    mg/.6mL & nbsp;   pegfilgrastim
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION
Coding System: National Drug Codes(NDC)

Labeler Information of NEULASTA

Product NDC: 54868-5229
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA125031
Marketing Category: BLA
Start Marketing Date: 20060223

Package Information of NEULASTA

Package NDC: 54868-5229-0
Package Description: 1 BLISTER PACK in 1 BOX (54868-5229-0) > 1 SYRINGE in 1 BLISTER PACK > .6 mL in 1 SYRINGE

NDC Information of NEULASTA

NDC Code 54868-5229-0
Proprietary Name NEULASTA
Package Description 1 BLISTER PACK in 1 BOX (54868-5229-0) > 1 SYRINGE in 1 BLISTER PACK > .6 mL in 1 SYRINGE
Product NDC 54868-5229
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name pegfilgrastim
Dosage Form Name INJECTION
Route Name SUBCUTANEOUS
Start Marketing Date 20060223
Marketing Category Name BLA
Labeler Name Physicians Total Care, Inc.
Substance Name PEGFILGRASTIM
Strength Number 6
Strength Unit mg/.6mL
Pharmaceutical Classes Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC]

Complete Information of NEULASTA


General Information